Navigation Links
Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills
Date:5/5/2008

New Survey of More Than 40,000 Readers Gives High Marks To Independent Drugstores For Service, Knowledge, and Speed; Sheds Light On Evolving Consumer-Pharmacist Relationship

YONKERS, N.Y., May 5 /PRNewswire-USNewswire/ -- For consumers who pay for all or most of their prescription drugs out of pocket, a new price study by Consumer Reports finds that it pays to shop around. Not only do prices vary from store to store for the same drug, but the fluctuations can be dramatic -- sometimes more than $100 for the same prescription -- even with the same chain, depending on whether consumers are filling their prescriptions in, say, Omaha, Nebraska, or Billings, Montana.

Consumer Reports placed more than 500 calls to 163 pharmacies nationwide to gauge price differences among four prescription drugs, three name brand medicines and one generic. For a three-month supply of pills for the urinary incontinence drug Detrol, for example, the price ranged from $365 to $551. CR also found significant price disparities for the two other name-brand drugs it studied: for Plavix (which prevents blood clots), the spread was $382-$541, and for Levoxyl (for treating hypothyroidism), prices ran from $29 to $85. And for the generic alendronate (for osteoporosis), the price range was $124 to $306.

In CR's small scale market-basket study, Costco was the cheapest for the four drugs CR sought quotes for, followed by AARP.com and Wal-Mart. Walgreens and Rite-Aid were among the priciest for the four drugs.

Besides calling different stores and comparison shopping, other cost-saving tips include:

-- Don't rule out independents: Though they're not the cheapest

overall, many mom-and-pop pharmacies are highly competitive and offer

top notch service.

-- Talk to your employer: Benefits administrators can provide details

about pharmacy benefit managers, also known as PBMs.

-- Buy generics: They can cost 2
'/>"/>

SOURCE Consumer Reports
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. State House Passes Bill to Help Consumers Struggling With High Summer Electric Bills
2. Whats Natural When it Comes to Personal Care Products? Consumers Finally Get Help with New Seal and Standard From the Natural Products Association
3. Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
4. Engaging Health Care Consumers Online is Top Priority
5. The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety
6. Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare.
7. Wal-Mart & Nalgene Removing Toxic Bottles, Place Consumers Concerns First
8. Soy Foods Beat Out Fresh Fish and Meat for Best New Products Tried By Consumers While Demand and Profits Continue to Grow
9. Consumer Watchdog Praises CA HMO Regulators Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered
10. Empowering consumers with their health records
11. Consumer Watchdog Applauds L.A. City Attorneys Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Orexigen 28R 29 Therapeutics to Speak at Canaccord Adams Global Growth Conference 13397 1Pharmasset to Present at Canaccord Adams Conference 13394 1Pharmasset to Present at Canaccord Adams Conference 13394 2Pharmasset to Present at Canaccord Adams Conference 13394 3Autism May Hinder Ability to Read Body Language 53773 1Autism May Hinder Ability to Read Body Language 53773 2